Skip to content

Corneal Endothelial Cell Loss in Diabetes Type II During Cataract Surgery

Corneal Endothelial Cell Loss in Diabetes Type II During Cataract Surgery

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00446277
Enrollment
30
Registered
2007-03-12
Start date
2007-01-31
Completion date
2007-06-30
Last updated
2008-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

cataract surgery, endothelial cell, cell loss, diabetes, mellitus type II

Brief summary

The aim of the present study is to evaluate changes in the morphology and function of the corneal endothelium before and after cataract surgery in patients with diabetes type II. Also to explain if determination of HgbA1c in diabetics is a predictor for the changes in morphology and function.

Detailed description

Thirty patients with Diabetes type II and thirty non-diabetes patients scheduled to cataract surgery (phacoemulsification with intraocular lens implantation) were invited to participate in the study. Preoperatively, all patients had a full eye examination and 3 endothelial cell photos were taken. Three months postoperatively the patients were called for a re-examination including 3 endothelial cell photos. The function of the cornea is dependent of the number and morphology of the endothelial cells, and even small traumas like cataract surgery may disrupt the cornea integrity leading to corneal haze and blur. Diabetics may be more vulnerable to corneal stress.

Interventions

PROCEDUREcataract surgery

Sponsors

Frederiksberg University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with cataract scheduled for surgery

Exclusion criteria

* Patients with corneal diseases, glaucoma or uveitis, previous intraocular surgery or eye traumas.

Design outcomes

Primary

MeasureTime frame
corneal endothelial cell count (cells / mm2)
percentage of hexagonal cells
variation in cell size
central corneal thickness

Secondary

MeasureTime frame
visual acuity
intraocular pressure

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026